FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2160979741> ?p ?o ?g. }

• W2160979741 endingPage "e671" @default.
• W2160979741 startingPage "e667" @default.
• W2160979741 abstract "Purpose To assess the potential reduction in breast dose for young girls with Hodgkin’s lymphoma (HL) treated with breast-sparing proton therapy (BS-PT) as compared with three-dimensional conformal involved-field photon radiotherapy (3D-CRT). Methods and Materials The Clarian Health Cancer Registry was queried for female pediatric patients with the diagnosis of HL who received radiotherapy at the Indiana University Simon Cancer Center during 2006–2009. The original CT simulation images were obtained, and 3D-CRT and BS-PT plans delivering 21 Gy or cobalt gray equivalent (CGE) in 14 fractions were created for each patient. Dose–volume histogram data were collected for both 3D-CRT and BS-PT plans and compared by paired t test for correlated samples. Results The cancer registry provided 10 female patients with Ann Arbor Stage II HL, aged 10–18 years at the time of treatment. Both mean and maximum breast dose were significantly less with BS-PT compared with 3D-CRT: 0.95 CGE vs. 4.70 Gy (p < 0.001) and 21.07 CGE vs. 23.11 Gy (p < 0.001), respectively. The volume of breast receiving 1.0 Gy/CGE and 5.0 Gy/CGE was also significantly less with BS-PT, 194 cm3 and 93 cm3, respectively, compared with 790 cm3 and 360 cm3 with 3D-CRT (p = 0.009, 0.013). Conclusion Breast-sparing proton therapy has the potential to reduce unnecessary breast dose in young girls with HL by as much as 80% relative to involved-field 3D-CRT. To assess the potential reduction in breast dose for young girls with Hodgkin’s lymphoma (HL) treated with breast-sparing proton therapy (BS-PT) as compared with three-dimensional conformal involved-field photon radiotherapy (3D-CRT). The Clarian Health Cancer Registry was queried for female pediatric patients with the diagnosis of HL who received radiotherapy at the Indiana University Simon Cancer Center during 2006–2009. The original CT simulation images were obtained, and 3D-CRT and BS-PT plans delivering 21 Gy or cobalt gray equivalent (CGE) in 14 fractions were created for each patient. Dose–volume histogram data were collected for both 3D-CRT and BS-PT plans and compared by paired t test for correlated samples. The cancer registry provided 10 female patients with Ann Arbor Stage II HL, aged 10–18 years at the time of treatment. Both mean and maximum breast dose were significantly less with BS-PT compared with 3D-CRT: 0.95 CGE vs. 4.70 Gy (p < 0.001) and 21.07 CGE vs. 23.11 Gy (p < 0.001), respectively. The volume of breast receiving 1.0 Gy/CGE and 5.0 Gy/CGE was also significantly less with BS-PT, 194 cm3 and 93 cm3, respectively, compared with 790 cm3 and 360 cm3 with 3D-CRT (p = 0.009, 0.013). Breast-sparing proton therapy has the potential to reduce unnecessary breast dose in young girls with HL by as much as 80% relative to involved-field 3D-CRT." @default.
• W2160979741 created "2016-06-24" @default.
• W2160979741 creator A5007860684 @default.
• W2160979741 creator A5014886040 @default.
• W2160979741 creator A5021052212 @default.
• W2160979741 creator A5043798566 @default.
• W2160979741 creator A5065914224 @default.
• W2160979741 date "2011-11-01" @default.
• W2160979741 modified "2023-09-26" @default.
• W2160979741 title "Dosimetric Comparison of Involved-Field Three-Dimensional Conformal Photon Radiotherapy and Breast-Sparing Proton Therapy for the Treatment of Hodgkin’s Lymphoma in Female Pediatric Patients" @default.
• W2160979741 cites W1987536026 @default.
• W2160979741 cites W2049649193 @default.
• W2160979741 cites W2050298407 @default.
• W2160979741 cites W2054310563 @default.
• W2160979741 cites W2068078001 @default.
• W2160979741 cites W2068279934 @default.
• W2160979741 cites W2098179714 @default.
• W2160979741 cites W2105900079 @default.
• W2160979741 cites W2106193652 @default.
• W2160979741 cites W2115362683 @default.
• W2160979741 cites W2121906079 @default.
• W2160979741 cites W2129146771 @default.
• W2160979741 cites W2133758798 @default.
• W2160979741 cites W2136761623 @default.
• W2160979741 cites W2137260575 @default.
• W2160979741 cites W2158734599 @default.
• W2160979741 cites W2162084836 @default.
• W2160979741 cites W2165459402 @default.
• W2160979741 doi "https://doi.org/10.1016/j.ijrobp.2011.01.061" @default.
• W2160979741 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21459527" @default.
• W2160979741 hasPublicationYear "2011" @default.
• W2160979741 type Work @default.
• W2160979741 sameAs 2160979741 @default.
• W2160979741 citedByCount "37" @default.
• W2160979741 countsByYear W21609797412012 @default.
• W2160979741 countsByYear W21609797412013 @default.
• W2160979741 countsByYear W21609797412014 @default.
• W2160979741 countsByYear W21609797412015 @default.
• W2160979741 countsByYear W21609797412016 @default.
• W2160979741 countsByYear W21609797412017 @default.
• W2160979741 countsByYear W21609797412018 @default.
• W2160979741 countsByYear W21609797412019 @default.
• W2160979741 countsByYear W21609797412020 @default.
• W2160979741 countsByYear W21609797412021 @default.
• W2160979741 countsByYear W21609797412022 @default.
• W2160979741 countsByYear W21609797412023 @default.
• W2160979741 crossrefType "journal-article" @default.
• W2160979741 hasAuthorship W2160979741A5007860684 @default.
• W2160979741 hasAuthorship W2160979741A5014886040 @default.
• W2160979741 hasAuthorship W2160979741A5021052212 @default.
• W2160979741 hasAuthorship W2160979741A5043798566 @default.
• W2160979741 hasAuthorship W2160979741A5065914224 @default.
• W2160979741 hasConcept C121608353 @default.
• W2160979741 hasConcept C126322002 @default.
• W2160979741 hasConcept C126838900 @default.
• W2160979741 hasConcept C2779244869 @default.
• W2160979741 hasConcept C2989005 @default.
• W2160979741 hasConcept C509974204 @default.
• W2160979741 hasConcept C530470458 @default.
• W2160979741 hasConcept C71924100 @default.
• W2160979741 hasConceptScore W2160979741C121608353 @default.
• W2160979741 hasConceptScore W2160979741C126322002 @default.
• W2160979741 hasConceptScore W2160979741C126838900 @default.
• W2160979741 hasConceptScore W2160979741C2779244869 @default.
• W2160979741 hasConceptScore W2160979741C2989005 @default.
• W2160979741 hasConceptScore W2160979741C509974204 @default.
• W2160979741 hasConceptScore W2160979741C530470458 @default.
• W2160979741 hasConceptScore W2160979741C71924100 @default.
• W2160979741 hasIssue "4" @default.
• W2160979741 hasLocation W21609797411 @default.
• W2160979741 hasLocation W21609797412 @default.
• W2160979741 hasOpenAccess W2160979741 @default.
• W2160979741 hasPrimaryLocation W21609797411 @default.
• W2160979741 hasRelatedWork W2005882420 @default.
• W2160979741 hasRelatedWork W2384708512 @default.
• W2160979741 hasRelatedWork W2477137756 @default.
• W2160979741 hasRelatedWork W2559422669 @default.
• W2160979741 hasRelatedWork W2797072917 @default.
• W2160979741 hasRelatedWork W2978475839 @default.
• W2160979741 hasRelatedWork W30869299 @default.
• W2160979741 hasRelatedWork W4322772323 @default.
• W2160979741 hasRelatedWork W83990173 @default.
• W2160979741 hasRelatedWork W935391112 @default.
• W2160979741 hasVolume "81" @default.
• W2160979741 isParatext "false" @default.
• W2160979741 isRetracted "false" @default.
• W2160979741 magId "2160979741" @default.
• W2160979741 workType "article" @default.